BH

Bo Hansen

President & CEO

Genevant Sciences

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Genevant Sciences
Industry
biotechnology
Employees
53.0
Seniority
C suite

Technologies

Mimecast Outlook Microsoft Office 365 Nginx Varnish Bootstrap Framework Mobile Friendly WordPress.org Typekit Remote Circle

Keywords

rna rare disease drug development biologics rnai mrna ind research lnp delivery drug delivery formulations lnp lipid nanoparticles sirna gene editing ligand conjugates oligonucleotides extrahepatic liver disease nucleic acid delivery lipid nanoparticle technology mrna delivery sirna delivery therapeutic proteins patent estate biodegradable lipids pharmaceutical development clinical trials cell types liver targeting ligand conjugate technology drug formulation endosomal release innovation in healthcare regulatory approval targeted delivery pharmacokinetics clinical applications molecular therapeutics collaboration with pharma experts in lipid chemistry multi-platform capabilities delivery technologies lyophilization supply chain efficiency therapeutic areas oncology applications vaccine technology rna interference pharmaceutical partnerships metabolic disorders patient-focused therapies biotechnology collaborations research publications impact on patient lives fda approval superior delivery system therapeutic advancements rna-based drugs manufacturing scale-up cutting-edge science lyophilized drug products extrahepatic delivery health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans